Ligand Pharmaceuticals Inc (LGND)
114.58
+0.64
(+0.56%)
USD |
NASDAQ |
Dec 20, 16:00
115.00
+0.42
(+0.37%)
After-Hours: 20:00
Ligand Pharmaceuticals Price: 114.58 for Dec. 20, 2024
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cellectar Biosciences Inc | 0.235 |
| Revance Therapeutics Inc | 3.08 |
| Pieris Pharmaceuticals Inc | 13.60 |
| Zymeworks Inc | 14.14 |
| CNS Pharmaceuticals Inc | 0.111 |
Price Related Metrics
| PE Ratio | 45.65 |
| PS Ratio | 13.58 |
| PEG Ratio | 0.2255 |
| Price to Book Value | 2.574 |
| Price to Free Cash Flow | 296.99 |
| Earnings Yield | 2.19% |
| Market Cap | 2.165B |
| PEGY Ratio | 0.2255 |
| Operating PE Ratio | 115.12 |